An oral treatment for iron overload in thalassemia?
Kowdley
K V
KV
Department of Medicine, University of Washington School of Medicine Seattle, USA.
Tavill
A S
AS
D000284:Administration, Oral; D015913:Chelation Therapy; D000077543:Deferiprone; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011728:Pyridones / Q000008:administration & dosage / Q000627:therapeutic use*; D013789:Thalassemia / Q000188:drug therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone